A community-driven hypertension treatment group in rural Honduras

References

• Lawes CMM, Vander Hoorn S, Rodgers A. Global burden of blood-pressure-related disease, 2001. Lancet. 2008; 371: 1513–18.
   Google Scholar
• Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, etal. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380: 2224–60.
   Google Scholar
• PAHO. Health System Profile Honduras, Central America: monitoring and analysis of health systems change/reform. 2009; Washington, DC: PAHO.
   Google Scholar
• Lehmann U, Sanders D. Community health workers: what do we know about them?. 2007; Geneva, Switzerland: WHO.
   Google Scholar
• Lorig KR, Ritter PL, González VM. Hispanic chronic disease self-management: a randomized community-based outcome trial. Nurs Res. 2003; 52: 361–9.
   Google Scholar
• Spencer MS, Rosland A-M, Kieffer EC, Sinco BR, Valerio M, Palmisano G, etal. Effectiveness of a community health worker intervention among African American and Latino adults with type 2 diabetes: a randomized controlled trial. Am J Public Health. 2011; 101: 2253–60.
   Google Scholar
• Allen JK, Dennison-Himmelfarb CR, Szanton SL, Bone L, Hill MN, Levine DM, etal. Community Outreach and Cardiovascular Health (COACH) Trial: a randomized, controlled trial of nurse practitioner/community health worker cardiovascular disease risk reduction in urban community health centers. Circ Cardiovasc Qual Outcomes. 2011; 4: 595–602.
   Google Scholar
• Lorig KR, Sobel DS, Stewart AL, Brown BW, Bandura A, Ritter P, etal. Evidence suggesting that a chronic disease self-management program can improve health status while reducing hospitalization: a randomized trial. Med Care. 1999; 37: 5–14.
   Google Scholar
• Kesselheim AS, Misono AS, Lee JL, Stedman MR, Brookhart MA, Choudhry NK, etal. Clinical equivalence of generic and brand-name drugs used in cardiovascular disease: a systematic review and meta-analysis. JAMA. 2008; 300: 2514–26.
   Google Scholar
• Housden L, Wong ST, Dawes M. Effectiveness of group medical visits for improving diabetes care: a systematic review and meta-analysis. CMAJ. 2013; 185: 635–44.
   PubMed Web of Science ®Google Scholar
• Loney-Hutchinson LM, Provilus AD, Jean-Louis G, Zizi F, Ogedegbe O, McFarlane SI. Group visits in the management of diabetes and hypertension: effect on glycemic and blood pressure control. Curr Diab Rep. 2009; 9: 238–42.
   Google Scholar
• Cohen LB, Taveira TH, Khatana SAM, Dooley AG, Pirraglia PA, Wu W-C. Pharmacist-led shared medical appointments for multiple cardiovascular risk reduction in patients with type 2 diabetes. Diabetes Educ. 2011; 37: 801–12.
   Google Scholar
• Kirsh S, Watts S, Pascuzzi K, O'Day ME, Davidson D, Strauss G, etal. Shared medical appointments based on the chronic care model: a quality improvement project to address the challenges of patients with diabetes with high cardiovascular risk. Qual Saf Health Care. 2007; 16: 349–53.
   Google Scholar
• PAHO. Managing hypertension in primary care in the Caribbean. 2007; St. Augustine, Trinidad & Tobago: Pan-American Health Organization.
   Google Scholar
• ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT). JAMA. 2002; 288: 2998–3007.
   PubMed Web of Science ®Google Scholar
• Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, etal. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003; 42: 1206–52.
   Google Scholar
• Hansson L, Zanchetti A, Carruthers SG, Dahlöf B, Elmfeldt D, Julius S, etal. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet. 1998; 351: 1755–62.
   Google Scholar
• WHO. WHO STEPS Surveillance Manual. 2008; Geneva, Switzerland: WHO.
   Google Scholar